p.antonsen
Submits third-party assay reports on material purchased directly. Based in Tours.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
99.37%
n=7
Suppliers covered
7
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041862 | ARA-290 | GSP | GSP-2605-K3362 | Janoshik | 2026-Q2 | 99.34 | 3.32 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043593 | BPC-157 | PPG | PPG-2601-P6797 | Kestrel | 2026-Q2 | 99.93 | 6.41 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041663 | PT-141 (Bremelanotide) | FGP | FGP-2602-Y8741 | Janoshik | 2026-Q2 | 99.33 | 4.04 | 91.4 | Buyer-sourced | 0 | PASS |
| AX-2026-043216 | GHRP-6 | SGN | SGN-2510-P8974 | Medutest | 2026-Q1 | 99.82 | 1.50 | 89.0 | Supplier-supplied | 3 | FAIL |
| AX-2026-042257 | KPV | TFC | TFC-2508-M9624 | Janoshik | 2026-Q1 | 99.54 | 2.81 | 95.6 | Buyer-sourced | 0 | FAIL |
| AX-2025-020384 | PT-141 (Bremelanotide) | MKM | MKM-2509-B4043 | Nordanalyt | 2025-Q4 | 99.37 | 6.07 | 88.6 | Laboratory-retained | 1 | MARGINAL |
| AX-2025-019751 | Tirzepatide | Homopeptide | HOMO-2502-U4118 | VendorInvestigate | 2025-Q2 | 98.58 | 6.11 | — | Buyer-sourced | 0 | PASS |